Tenax Therapeutics
(TENX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 01-2014 | 10-2013 | 07-2013 | 04-2013 | 01-2013 | |
| Sales | 42 | 59 | 193 | 0 | 224 |
| Cost of Goods | 0 | 3 | 28 | N/A | 2 |
| Gross Profit | 42 | 56 | 166 | N/A | 222 |
| Operating Expenses | 2,474 | 2,173 | 1,783 | 0 | 1,815 |
| Operating Income | -2,431 | -2,114 | -1,590 | N/A | -1,592 |
| Interest Expense | 70 | 1,417 | 656 | 0 | 822 |
| Other Income | -850 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -3,351 | -3,532 | -2,245 | 0 | -2,413 |
| Net Income Continuous | -3,351 | -3,532 | -2,245 | N/A | -2,413 |
| Net Income | $-3,351 | $-3,532 | $-2,245 | $N/A | $-2,413 |
| EPS Basic Total Ops | -13,760.00 | -39,360.00 | -65,919.99 | N/A | -46,400.00 |
| EPS Basic Continuous Ops | -10,451.21 | -22,866.77 | -34,164.86 | N/A | -46,545.75 |
| EPS Diluted Total Ops | -14,080.00 | -40,000.00 | -107,520.00 | N/A | -88,959.99 |
| EPS Diluted Continuous Ops | -10,444.09 | -22,834.42 | -32,510.72 | N/A | -43,682.27 |
| EBITDA(a) | $-2,118 | $-2,039 | $-1,590 | $N/A | $-1,517 |